Novo Nordisk shares fall as weight loss trial data disappoints

Open Editor's Digest for free Roula Khalaf, Editor of the FT, selects her favorite stories for this weekly newsletter. Novo Nordisk, one of Europe's biggest companies, lost more than a quarter of its value on Friday after its latest obesity…